【 AP2關(guān)聯(lián)激酶1抗體】齊一生物科技（上海）有限公司檢測(cè)試劑盒產(chǎn)品已被廣泛應(yīng)用于化學(xué)、化工、生命科學(xué)的基礎(chǔ)研究和開(kāi)發(fā)應(yīng)用、制藥、疾病診斷與控制、人口與健康、生物技術(shù)等諸多領(lǐng)域�？蛻舯椴紘�(guó)內(nèi)各大學(xué)、研究所、醫(yī)院、衛(wèi)生防疫、商品檢驗(yàn)檢疫、制藥公司、生物技術(shù)公司和食品工業(yè)等單位。【 AP2關(guān)聯(lián)激酶1抗體】齊一生物銷售：021－6034 8496；181214 53965；173021 04490網(wǎng)址：www.qiyibio.com

5000-1404      Plate Cartridge 110V, VTX2          CNY                           

5000-1277      Top Housing W LID, DML2         CNY                           

5050-1029      Mouse, PC System spare             CNY                           

5025-1011      Expand 4 Pipettor 240V        CNY                           

9240747  Belt, Reagent Pump 117 groove, AP             CNY                           

9240720  Cable Carrier, Tubing, Dispense Head, AP           CNY                           

9240700  Tubing, Waste, 1 1\4", AP            CNY                           

9243690  DML Luminometer, Repair Fee     DML Repair Fee covers Regional Repair Center service for non-service agreement covered DML 2000 ａnd DML 3000 units. Includes labor, parts ａnd shipping materials.     CNY                           

9243652  Comprehen Valid., QuantiPlex/QP Hyres       """The Comprehensive Validation Support plan specific to a laboratory＇s needs will incorporate all of the requirements for the internal validation guidelines from the FBI＇s Quality Assurance Standards (QAS).

The Comprehensive Validation Support service includes all travel ａnd labor charges for up to 20 days by the QIAGEN Validation Team. Typically, one week will be required to extract, quantify, ａnd amplify the validation study samples ａnd may require multiple individuals. Usually, two weeks is required to analyze the data ａnd one week to write the final report. The expected time period to complete the Comprehensive Validation is six weeks. The actual time may vary depending on resource availability, including laboratory time dedicated to validation activities.

Lab Work – The QIAGEN specialist(s) will travel to the laboratory to conduct the on-site validation lab work. The QIAGEN specialist team will perform ａnd complete all extractions, quantifications, amplfications, ａnd capillary electrophoresis. The laboratory is responsible for providing systems/protocols that may be needed (generally laboratory SOPs, ex. interpretation guidelines). Additionally, the laboratory staff may be required to provide additional data needed for interpretation (ex. quantification/amplification/CE results) during the data review phase of the validation.

Once the final scope of the validation is determined, QIAGEN will provide a quote for all consumables required for the validation.  Non-QIAGEN chemistry ａnd accessories are not included ａnd should  be purchased to cover the validation experimental design including qPCR, STR, NIST standards, required samples types (blood, semen, buccal samples) ａnd required substrates (swabs, materials, etc).   For planning purposes ａnd to ensure a smooth process, the Customer is expected to have all materials on-hand ａnd inventoried one (1) week prior to the validation start date.

Data Analysis – The Comprehensive Validation Support plan encompasses data collection (quants, amps, CE) during the on-site visit. The laboratory may be responsible for sharing (typically electronically via e-mail) any validation data requested after the on-site visit. A QIAGEN specialist will complete all of the data analysis produced from the validation study design. This includes qPCR (quant) ａnd STR (amp) analysis ａnd linkage to starting samples.

Validation data CD/flashdrive – QIAGEN will review the validation data ａnd draft a validation summary document, ensuring compliance with the FBI＇s QAS requirements/standards. QIAGEN will send validation data in an electronic format (email/CD/flashdrive) to the laboratory. The laboratory is responsible for final compilation, any format change preferences, review ａnd signoff of the validation report. The documentation provided by QIAGEN will aide in demonstrating compliance with all accreditation guidelines during laboratory audits. Should a hard copy of the validation study be preferred, the laboratory is required to specify prior to the onset of the validation.

Post-validation QIAGEN-to-Laboratory Transfer – Following completion of the validation ａnd generation of the draft validation summary document, a designated member of the QIAGEN validation team will review the validation with the Lab Manager ａnd the Technical Leader. Following sign off on the validation report, training of the laboratory DNA staff will occur. Refer to the Post-validation Competency Training for additional information. """   CNY                             AP2關(guān)聯(lián)激酶1抗體

6000-3101      Rapid Capture System           CNY                           

19134     QIAGEN Proteinase K          CNY                           

614033    careHPV Test, SFDA (24-test)             CNY                           

274203    flocktype IBDV Ab (5)          CNY                           

270803    cattletype MAP Ab (5)           CNY                           

280303    cador BVDV RT-PCR Kit (24)             CNY                           

282303    virotype PRRSV RT-PCR Kit (24)        CNY                           

282305    virotype PRRSV RT-PCR Kit (96)        CNY                           

280443    virotype BTV pan/8 RT-PCR Kit (24)           CNY                           

939012    Buffer N2 (2 x 10 ml)           CNY                           

871105    EGFR PCR Kit (100)            CNY                           

800382    Restriction Map             CNY                           

871005    KRAS PCR Kit (100)            CNY                           

9020586  Power Supply, 24V 60W, DML 3000           CNY                           

9013314  Shaker adapter, 192-tube, 5 ml             CNY                           

9013211  Cabling kit, data, BR8000             CNY                             AP2關(guān)聯(lián)激酶1抗體

9011747  Worktable left, BR8000 v1.01              CNY                           

132568    NeXtal Stock Methoxy-PEG 5000 (50) 30% w/v Methoxypolyethylene glycol 5000 - 50mL (4 x 12,5 ml tube)      CNY                           

800311    Custom Primer              CNY                           

766134    PAXgene Tissue miRNA Kit (50)          CNY                           

QY-x2372       人胚肺細(xì)胞WI-38                                   

QY-x2373       非洲綠猴腎細(xì)胞Vero                                      

QY-x2374       細(xì)胞淋巴瘤細(xì)胞U-937                                   

QY-x2375       人腦星形膠質(zhì)母細(xì)胞瘤U-87MG                                   

QY-x2376       人膠質(zhì)瘤細(xì)胞U251                                        

QY-x2377       人骨肉瘤細(xì)胞U-2OS                                      

QY-x2378       單核細(xì)胞系THP-1                                         

QY-x2379       人血液白血病細(xì)胞TF-1                                        

QY-x2380       人舌鱗癌細(xì)胞Tca-8113                                           AP2關(guān)聯(lián)激酶1抗體

QY-x2381       蝙蝠肺細(xì)胞Tb1Lu                                         

QY-x2382       人乳腺管癌細(xì)胞T-47D                                   

QY-x2383       人膀胱移行細(xì)胞癌細(xì)胞T-24                                         

QY-x2384       人結(jié)腸癌細(xì)胞SW620                                     

QY-x2385       人甲狀腺鱗癌細(xì)胞SW579                                     

QY-x2386       人結(jié)腸癌細(xì)胞SW[SW-]                                        

QY-x2387       豬睪丸細(xì)胞系ST                                    

QY-x2388       小鼠骨髓瘤細(xì)胞SP2/0                                   

QY-x2389       人肝癌細(xì)胞SMMC-7721                                       

QY-x2390       人卵巢癌細(xì)胞SK-OV-3                                         

QY-x2391       人肝癌細(xì)胞SK-HEP-1                                    

QY-x2392       人乳腺腺癌細(xì)胞SK-BR-3                                      

QY-x2393       人子宮頸鱗癌細(xì)胞SiHa                                         

QY-x2394       人膠質(zhì)瘤細(xì)胞SHG-44                                    

QY-x2395       人胃癌SGC7901                                     

QY-x2396       人成骨肉瘤細(xì)胞Saos-2                                         

QY-x2397       大鼠雪旺細(xì)胞RSC96                                     

QY-x2398       小鼠前列腺癌細(xì)胞RM-1                                         AP2關(guān)聯(lián)激酶1抗體

QY-x2399       人結(jié)腸腺癌細(xì)胞RKO                                     

QY-x2400       猴脈絡(luò)膜-視網(wǎng)膜(內(nèi)皮)細(xì)胞RF/6A                                      

QY-x2401       小鼠單核巨噬細(xì)胞白血病細(xì)胞RAW264.7                                   

QY-x2402       人Burkitt＇s淋巴瘤細(xì)胞Raji